William A. Bornstein, MD, PhD
Chief Medical and Quality Officer
Patient Safety Officer
Dr. Bornstein has served as Chief Medical Officer and Chief Quality Officer for Emory Healthcare since September of 2003. He was also named Patient Safety Officer in 2017. He was appointed Chief Quality Officer and Associate Administrator of Emory Crawford Long Hospital in 1999 a role that was expanded to encompass the Emory Hospitals starting in 2000 and Emory Healthcare, in 2003. In 2006 he was also named Chief Medical Officer of Emory Healthcare. In these roles, Dr. Bornstein has led the development of a quality and safety program that has been highly successful and visible and has been recognized by a number of awards. In 2006, he led a major expansion of the Emory Healthcare quality program with the formation of a new Emory Healthcare Office of Quality. The Office of Risk and Insurance Services merged with the Office of Quality in 2009, to form the Emory Healthcare Office of Quality and Risk, which Dr. Bornstein directs.
Dr. Bornstein has been a champion of the use of information technology to improve healthcare quality. Before assuming his Chief Quality Officer role, he served as the Medical Director of the Emory Healthcare Information Services Department starting in 1996 (referred to as Director of Clinical Development from 1996 to 2001). In this role Dr. Bornstein was a leader in the development of the Emory Healthcare clinical data repository (one of the largest of its kind in the world) and is now a leader of the Emory Electronic Medical Records Project that is implementing clinically transformative technology on the foundation established by the clinical data repository. As Chief Quality and Medical Officer, Dr. Bornstein has retained a focus on ensuring that that implementation of this technology leads to breakthrough improvements in clinical quality and patient safety.
Dr. Bornstein is a Board-certified internist and endocrinologist and continues to care for patients. He received his undergraduate degree in mathematics from Dartmouth College and his M.D. and Ph.D. (Cell & Molecular Biology) from the Medical College of Georgia. He did his internal medicine training at Duke, where he served as assistant chief resident, and his fellowship in endocrinology and metabolism at the Massachusetts General Hospital (MGH) and Harvard Medical School. After completing his fellowship, Dr. Bornstein stayed on at the MGH working on the molecular biology of calcium regulation in the laboratory of Dr. Henry Kronenberg, before moving to Atlanta in 1986.
Dr. Bornstein is a recognized leader in quality, safety, and the use of information technology in improving healthcare delivery. He has served on a number of national committees and advisory bodies in these areas including the Clinical Evaluative Sciences Council Steering Committee and the Risk Adjustment Task Force of the University HealthSystem Consortium (UHC), the Professional and Technical Advisory Committee for the hospital accreditation process of The Joint Commission, the Standards and Survey Procedures Committee of the Joint Commission, and the steering committees of the Integrating Quality Initiative and Variations Initiative of the Association of American Medical Colleges . Dr. Bornstein was a reviewer for the 2003 Institute of Medicine report, Patient Safety: Achieving a New Standard of Care and is a member of the Staff Leadership Group for the IOM Roundtable on Evidence-Based Medicine. He is on the editorial board of the Journal of Clinical Outcomes Management and has been series editor for The Emory Initiatives appearing in that journal.